Applied Clinical Trials
October 01, 2015
News
24
10
Addressing the challenges unique to purely industry-sponsored trials is explored.
October 01, 2015
News
24
10
HH
October 01, 2015
View from Brussels
24
10
Several initiatives are focused on integrating biomarkers and personalized medicine techniques into studies.
October 01, 2015
A Closing Thought
24
10
Aligning patient-centric approaches with personalized medicine and biomarker use is transforming the design of Alzheimer's trials.
October 01, 2015
News
24
10
A review of public data indicates a small increase in Phase III inclusion/exclusion criteria per trial over a five-year period.
October 01, 2015
CTI Insights
24
10
Survey provides new benchmarks on e-solutions adoption, but actual impact data remains elusive.
October 01, 2015
Feature Article
24
10
This experimental technique is being studied to see whether it could treat certain health problems.
October 01, 2015
Feature Article
24
10
Examining the practical significance of reporting patient deaths due to main disease progression.
October 01, 2015
Feature Article
24
10
Using a specific trial, the importance of assessing the success of therapy masking is examined.
October 01, 2015
Feature Article
24
10
Survey applies rigorous analysis to provide a rare formal look at volunteer satisfaction in early setting.
October 01, 2015
Issue PDF
24
10
Trial Design: Gene Transfer: Key Challenges Therapy Masking Assessment Safety Reporting: Death Waivers Fall Short Subject Engagement: Phase I Satisfaction Scores Also in this issue: Informed Consent Changes in Works Europe's Embrace of New Science Alzheimer's and Patient Safety